Quality and Regulatory Compliance in Bioscience

by Emalee MacKenzie

This text provides a comprehensive overview of quality control, assurance, and regulatory environments within the biotechnology and biomanufacturing industries. Students study the role of the FDA, major regulatory frameworks (including the FD&C Act), and critical industry compliance systems like Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP).

Description from LibreTexts.

Publisher
Irvine Valley College
Subjects
Biology
Licence
CC BY-SA 4.0, as LibreTexts states it
Who can read
Tweens profiles and older, judged from its title and subjects

Contents

LibreTexts writes equations in TeX, and here they show as TeX; the PDF has them typeset.

  1. Front Matter
  2. TitlePage
  3. InfoPage
  4. Table of Contents
  5. Licensing
  6. How To Use This Workbook
  7. 1: The Organization of a Biotechnology Company
  8. 1.1: How Biotechnology Companies Are Organized
  9. 1.2: Research and Development
  10. 1.3: Process Development and Manufacturing
  11. 1.4: The Quality Department
  12. 1.5: Regulatory Affairs and Product Studies
  13. 1.6: Supply Chain and Facilities
  14. 1.7: Commercial Teams and Business Support
  15. 1.8: Example - A Shipment Arrives Warm
  16. 1.9: Chapter Summary
  17. 2: Understanding Quality
  18. 2.1: Definitions of quality in products, services, and processes
  19. 2.2: Customer requirements, expectations, and fitness for use
  20. 2.3: Quality assurance, quality control, and quality improvement
  21. 2.4: Prevention, detection, and correction of problems
  22. 2.5: Quality responsibilities throughout an organization
  23. 2.6: Costs and consequences of poor quality
  24. 2.7: When a diagnostic result could not be trusted
  25. 2.8: Applying quality terminology in different workplace settings
  26. 2.9: Chapter summary
  27. 3: Quality Philosophies and Improvement Frameworks
  28. 3.1: Development of modern quality management
  29. 3.2: Shewhart’s contributions and the PDCA improvement cycle
  30. 3.3: Deming’s management philosophy and 14 points
  31. 3.4: Juran’s trilogy- planning, control, and improvement
  32. 3.5: Ishikawa’s contributions to participation and cause analysis
  33. 3.6: Crosby’s prevention approach and zero-defects philosophy
  34. 3.7: Comparing philosophies and selecting useful applications
  35. 3.8: Distinguishing management philosophies from individual tools
  36. 3.9: Chapter Summary
  37. 4: Quality Plans and Organizational Responsibility
  38. 4.1: Purpose and scope of a quality plan
  39. 4.2: Connecting quality objectives to organizational strategy
  40. 4.3: Translating requirements into responsibilities and activities
  41. 4.4: Example of translating one requirement
  42. 4.5: Contributions from management, operations, quality, purchasing, and support functions
  43. 4.6: Training, resources, documentation, and communication
  44. 4.7: Performance measures and review schedules
  45. 4.8: Updating a quality plan when requirements or processes change
  46. 4.9: Example - When a bottle shortage challenged laboratory planning
  47. 4.10: Chapter summary
  48. 5: Systems, Processes, and SIPOC
  49. 5.1: Distinguishing a system from a process
  50. 5.2: Relationships among processes within a system
  51. 5.3: SIPOC- suppliers, inputs, process, outputs, and customers
  52. 5.4: Defining process boundaries and requirements
  53. 5.5: Creating and interpreting a SIPOC diagram
  54. 5.6: Handoffs, feedback, and interactions among functional areas
  55. 5.7: A decision that depended on the manufacturing system
  56. 5.8: Recognizing unintended consequences of local improvements
  57. 5.9: Chapter summary
  58. 6: Variation and Process Performance
  59. 6.1: Why repeated process results differ
  60. 6.2: Common-cause and special-cause variation
  61. 6.3: Process stability and predictable performance
  62. 6.4: Distinguishing specification limits from control limits
  63. 6.5: Responding appropriately to different sources of variation
  64. 6.6: A children’s medicine recall brings variation into focus
  65. 6.7: Risks of adjusting a stable process unnecessarily
  66. 6.8: Using variation knowledge to guide improvement
  67. 6.9: Chapter summary
  68. 7: Employee Involvement and Empowerment
  69. 7.1: Employee involvement- contributing knowledge and participating in improvement
  70. 7.2: Employee empowerment- authority to make decisions within defined boundaries
  71. 7.3: Differences and relationships between involvement and empowerment
  72. 7.4: Benefits for employees, customers, and organizations
  73. 7.5: Leadership support, training, and access to information
  74. 7.6: Accountability, escalation, and decision authority
  75. 7.7: Giving operators a better way to decide
  76. 7.8: Recognizing barriers to meaningful participation
  77. 7.9: Chapter summary
  78. 8: Team Purpose, Types, and Responsibilities
  79. 8.1: Why teams can improve problem identification and resolution
  80. 8.2: Teams compared with individual work and loosely organized groups
  81. 8.3: Process teams and continuous improvement team
  82. 8.4: Workgroups and workcells
  83. 8.5: Self-managed teams
  84. 8.6: Temporary and ad hoc project teams
  85. 8.7: Cross-functional teams
  86. 8.8: Selecting a team structure for the situation
  87. 8.9: Example - choosing a team for batch-document delays
  88. 8.10: Sponsor, champion, facilitator, leader, and member responsibilities
  89. 8.11: Connecting team efforts to organizational strategy
  90. 8.12: Chapter Summary
  91. 9: Launching and Sustaining a Team
  92. 9.1: Developing a team charter
  93. 9.2: Example- Freezer-alarm handoff team charter
  94. 9.3: Establishing purpose, scope, goals, and expected results
  95. 9.4: Selecting members for knowledge, skills, representation, and diversity
  96. 9.5: Establishing ground rules and decision authority
  97. 9.6: Planning schedules, meeting logistics, and resources
  98. 9.7: Securing management support
  99. 9.8: Example - Building a shared response through ACTIV
  100. 9.9: Stages of team development
  101. 9.10: Tracking actions, progress, and accountability
  102. 9.11: Sustaining participation and recognizing contributions
  103. 9.12: Chapter Summary
  104. 10: Communication, Conflict, and Team Decisions
  105. 10.1: Active listening and constructive communication
  106. 10.2: Recognizing productive disagreement and harmful conflict
  107. 10.3: Addressing conflict respectfully
  108. 10.4: A missed review handoff
  109. 10.5: Groupthink and barriers to independent judgment
  110. 10.6: A recommendation changes before Challenger launches
  111. 10.7: Poor logistics, unclear agendas, and training gaps
  112. 10.8: Voting and consensus
  113. 10.9: Selecting an appropriate decision method
  114. 10.10: Confirming agreement and recording decisions
  115. 10.11: Follow-up techniques and action verification
  116. 10.12: Chapter Summary
  117. 11: The Regulation of Medical and Food Products
  118. 11.1: History of Regulations in the Pharmaceutical Industry
  119. 11.2: The Food and Drug Administration (FDA)
  120. 11.3: FDA Centers and Programs
  121. 11.4: Rulemaking Adjudication and Guidance
  122. 11.5: The Code of Federal Regulations (CFR)
  123. 11.6: Selected Regulations Relevant to Biotechnology
  124. 11.7: Current Good Manufacturing Practice
  125. 11.8: Good Clinical Practice
  126. 11.9: International Harmonization Efforts
  127. 11.10: Regulation of Food and Agriculture in the United States
  128. 11.11: Food Safety
  129. 11.12: Laws Governing Food and Agricultural Biotechnology
  130. 11.13: Regulation of Agricultural Biotechnology and GMOs
  131. 11.14: Chapter Summary
  132. 12: Drug Development, Approval, and Postmarket Oversight
  133. 12.1: From Discovery to the Market
  134. 12.2: Discovery and Nonclinical Development
  135. 12.3: Clinical Development and Participant Protection
  136. 12.4: FDA Marketing Review and Other Pathways
  137. 12.5: Manufacturing Quality and Contamination Prevention
  138. 12.6: Postmarket Monitoring and Recall Decisions
  139. 12.7: Inspections and Enforcement
  140. 12.8: Case Study McNeil Recalls and FDA Oversight
  141. 12.9: Chapter Summary
  142. 13: Quality Documentation
  143. 13.1: The Importance of Documentation
  144. 13.2: Types of Documentation
  145. 13.3: Good Documentation Practices
  146. 13.4: Signatures and Independent Verification
  147. 13.5: Laboratory Notebooks
  148. 13.6: Standard Operating Procedures
  149. 13.7: Forms, Protocols & Reports
  150. 13.8: Reports
  151. 13.9: Equipment and Instrument Logbooks
  152. 13.10: Instrument and Computer Records
  153. 13.11: Analytical Laboratory Documentation
  154. 13.12: Identification Systems and Labels
  155. 13.13: Chain of Custody
  156. 13.14: Training Records
  157. 13.15: Master and Completed Batch Records
  158. 13.16: Regulatory Submissions and Product Release
  159. 13.17: Electronic Documentation
  160. 13.18: Managing Changes in Documentation
  161. 13.19: Storage Retention and Retrieval
  162. 13.20: Documentation Requirements and Oversight
  163. 13.21: Chapter Summary
  164. 14: Quality Systems in the Laboratory and Production Facility
  165. 14.1: General Principles and Laboratory Management
  166. 14.2: Facilities and Equipment in Production
  167. 14.3: Handling Raw Materials and Components
  168. 14.4: Example - Material Specification Fields
  169. 14.5: Establishing Specifications
  170. 14.6: Processes and In Process Controls
  171. 14.7: Example of a Mammalian Cell Culture Process
  172. 14.8: Out of Specification Results
  173. 14.9: Change Control and Emergency Actions
  174. 14.10: Designing a Controlled Manufacturing Process
  175. 14.11: Calibration Verification Qualification and Validation
  176. 14.12: Process Validation Across the Life Cycle
  177. 14.13: Process and Analytical Method Validation
  178. 14.14: Example - Testing a Bioreactor Temperature Control System
  179. 14.15: Sterilization Validation as an Example
  180. 14.16: Maintaining Control and Handling Unplanned Events
  181. 14.17: Workplace Hazards in Biotechnology
  182. 14.18: Choosing and Checking Exposure Controls
  183. 14.19: Mock Audit of Sample Receiving
  184. 14.20: Chapter Summary
  185. 15: Quality Assays (1)
  186. 15.1: Categories of Quality Tests
  187. 15.2: Selecting and Establishing a Method
  188. 15.3: The Sample
  189. 15.4: Sample Preparation and Recovery
  190. 15.5: Reference Materials Standards and Controls
  191. 15.6: Analytical Method Validation
  192. 15.7: Measurement Error and Accuracy
  193. 15.8: Precision
  194. 15.9: Detection and Quantitation Limits
  195. 15.10: Specificity and Selectivity
  196. 15.11: Calibration Model Linearity and Range
  197. 15.12: Robustness and Intermediate Precision
  198. 15.13: System Suitability
  199. 15.14: Organizing Quantitative Data
  200. 15.15: Graphs
  201. 15.16: Standard Curves and Linear Regression
  202. 15.17: Unknown and Dilution Example
  203. 15.18: Chapter Summary
  204. Back Matter
  205. Index
  206. Glossary
  207. Detailed Licensing
  208. Detailed Licensing